作者
寇 玉,南晓东,张群康,王尖措吉,汪晨净
文章摘要
西红花酸作为西红花的主要活性成分,其独特的多不饱和共轭烯酸结构赋予了它丰富的药理作用。现代药理学研究揭示,西红花酸在心脏保护、肝脏保护、神经保护、抗抑郁、抗病毒、抗癌、抗动脉粥样硬化、抗糖尿病以及提高记忆等方面都有显著效果。为了更深入挖掘西红花酸在心血管疾病中应用的潜力,本文将对近年来西红花酸的心血管药理作用研究进展作以综述,以期为今后的研究及药物临床应用提供有力的理论指导。
文章关键词
西红花酸;动脉粥样硬化;心血管系统;药理作用
参考文献
[1] 郑优优,陈莹,许琦伟,等.番红花的化学成分及其药理作用研究进展[J].植物生理学报,2024,60(01):20-34.
[2] Fan J,Watanabe T.Atherosclerosis:Known and unknown.Pathol Int[J].2022,72(3):151-160.
[3] 李伊凡,刘晋星,党爱民.血管内皮细胞功能障碍与动脉粥样硬化研究进展[J].中华高血压杂志,2023,31(12):1179-1183.
[4] 向敏,王建梅,周成华,等.西红花酸对AGEs诱导血管内皮细胞通透性增加的抑制作用[J].中国药理学通报,2011,27(09):1254-1259.
[5] Xu G L,Gong Z N,Yu W P,et al.Increased expression ratio of Bcl-2/Bax is associated with crocin-mediated apoptosis in bovine aortic endothelial cells[J].Basic Clin Pharmacol Toxicol,2007,100(1):31-35.
[6] Go GW,Mani A.Low-density lipoprotein receptor(LDLR)family orchestrates cholesterol homeostasis.Yale J Biol Med[J].2012,85(1):19-28.
[7] 杜林芳,练静,李阳,等.PCSK9在心血管疾病中的研究进展[J].心脏杂志,2024(03):324-328
[8] Gustafsen C,Kjolby,M,Nyegaard M,et al.The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion[J].Cell Metab,2014,19(2):310-318.
[9] Siddiq A A,Martin A.Crocetin exerts hypocholesterolemic effect by inducing LDLR and inhibiting PCSK9 and Sortilin in HepG2 cells[J].Nutr Res,2022,98:41-49.
[10] 乔莞宁,陈虹印,张扬.氧化应激与动脉粥样硬化[J].中国动脉硬化杂志,2023,31(04):312-321.
[11] 石磊.西红花酸体内外抗氧化作用的研究[J].中国医药指南,2012,10(15):118-120.
[12] 陈阳,杨婷,黄娟,等.西红花苷和西红花酸在小鼠体内抗氧化活性对比研究[J].中国药理学通报,2010,26(02):248-251.
[13] Kong P,Cui ZY,Huang XF,et al.Inflammation and atherosclerosis:signaling pathways and therapeutic intervention[J].Signal Transduct Target Ther.2022,7(1):131.
[14] 田丁阳,张敬,杨宏博,等.中药通过调控MAPK通路治疗心脑血管疾病研究进展[J].中医学报,2023,38(06):1216-1222.
[15] Diao S L,Sun J W,Ma BX,et al.Influence of crocetin on high-cholesterol diet induced atherosclerosis in rats via anti-oxidant activity together with inhibition of inflammatory response and P38 MAPK signaling pathway[J].Saudi J Biol Sci,2018,25(3):493-499.
[16] ZHONG Z J,WU Y Z,XU F F,et al.Inhibition of crocetin on proliferation and migration of vascular smooth muscle cells induced by PDGF-BB[J].Mod J Intergr Tradit Chin West Med(现代中西医结合杂志),2019,28(25):2751-2754.
[17] Zheng S G,Qian Z Y,Wen N,et al.Crocetin suppresses angiotensin II-induced vascular smooth-muscle cell proliferation through inhibition of ERK1/2 activation and cell-cycle progression[J].J Cardiovasc Pharmacol,2007,50(5):519-525.
[18] Oldfield CJ,Duhamel TA,Dhalla NS.Mechanisms for the transition from physiological to pathological cardiac hypertrophy[J].Can J Physiol Pharmacol.2020,98(2):74-84.
[19] Cai J,Yi F F,Bian Z Y,et al.Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway[J].J Cell Mol Med,2009,13(5):909-925.
[20] 沈祥春,钱之玉.西红花酸对压力超负荷致心肌肥厚大鼠的ATPase及胶原的影响[J].中草药,2003(06):57-60.
[21] 韩笑,郭浩,杨斌.丹红滴丸调节Bcl-2/Bax-Cyt-C-Caspase-3抑制心肌缺血再灌注大鼠心肌细胞凋亡[J].中药药理与临床,2020,36(03):154-158.
[22] 韩笑,王攀,刘建勋,等.西红花酸对阿霉素诱导大鼠心肌细胞损伤的影响[J].中国中医药信息杂志,2021,28(10):64-69.
[23] 赵志峰,王红芳,张建平,等.西红花酸对三氧化二砷诱导大鼠心肌损伤的保护作用[J].中国新药与临床杂志,2021,40(01):58-63.
[24] 高原,于文慧,张美君,等.Nrf2/HO-1信号通路与缺血再灌注损伤的研究进展[J].中国中西医结合外科杂志,2020,26(04):776-778.
[25] Yang M,Mao G X,Ouyang L L,et al.Crocetin alleviates myocardial ischemia/reperfusion injury by regulating inflammation and the unfolded protein response[J].Mol Med Rep,2020,21(2):641-648.
[26] 寇鑫晖,钱之玉.西红花酸对大鼠心肌缺血再灌注损伤的保护作用[J].中草药,2008(07):1049-1053.
[27] 江山山,蒋锦燕,李桥桥等.西红花与红花的抗血栓作用研究[J].中草药,2021,52(12):3584-3590.
[28] Higashino S,Sasaki Y,Giddings JC,et al.Crocetin,a carotenoid from Gardenia jasminoides Ellis,protects against hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats[J].Phytother Res.2014,28(9):1315-1319.
Full Text:
DOI